COMPANY
Sydnexis
Timeline
- Trial start Phase 3: The Safety and Efficacy of SYD-101 in Children With Myopia source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT03918915 | The Safety and Efficacy of SYD-101 in Children With Myopia | Phase 3 | Completed | Apr 24, 2019 | May 2, 2024 (actual) |